ESSENTIAL THROMBOCYTHEMIA (ET)
Clinical trials for ESSENTIAL THROMBOCYTHEMIA (ET) explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL THROMBOCYTHEMIA (ET) trials appear
Sign up with your email to follow new studies for ESSENTIAL THROMBOCYTHEMIA (ET), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare blood cancers in early trial
Disease control Recruiting nowThis study tests a new daily pill called JBI-802 in people with certain blood cancers (myeloproliferative neoplasms and MDS/MPN) who have too many platelets. The trial has two phases: first, finding a safe dose in about 30 adults, then checking if it works. Participants take the …
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a $10 arthritis pill tame rare blood cancers?
Disease control Recruiting nowThis study tests low-dose methotrexate, a common arthritis drug, in 54 people with three rare blood cancers: polycythemia vera, essential thrombocythemia, and myelofibrosis. Researchers want to see if it can shrink spleens, improve symptoms, and lower blood counts safely. If succ…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Scientists hunt for immune cells that could lead to new MPN therapies
Knowledge-focused Recruiting nowThis study looks at how the immune system reacts to myeloproliferative neoplasms (MPN), a group of blood cancers. Researchers will collect blood and bone marrow samples from 150 adults with or without MPN to find special immune cells (T cells) that recognize and attack MPN cells.…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Thousands with blood diseases to be tracked in massive chinese registry
Knowledge-focused Recruiting nowThis study is creating a large database of people in China with various blood diseases, such as leukemia, multiple myeloma, and hemophilia. Researchers will collect information from medical records and follow participants over time to learn about disease patterns, treatments, and…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC